193 related articles for article (PubMed ID: 7638781)
1. [The evolution of the concepts of systemic scleroderma].
Guseva NG
Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
[No Abstract] [Full Text] [Related]
2. [The evolution of juvenile systemic scleroderma].
Starovoĭtova MN; Guseva NG
Ter Arkh; 1997; 69(11):55-60. PubMed ID: 9483750
[TBL] [Abstract][Full Text] [Related]
3. [News about scleroderma: survey of present state of research problems (author's transl)].
Stáva Z; Kobíková M; Kolár J; Drugová B
Cas Lek Cesk; 1974; 113(26):787-92. PubMed ID: 4844781
[No Abstract] [Full Text] [Related]
4. [Medical disability expertise in systemic scleroderma].
Shabel'nik VI; Tsyban' ME; Filiuk VF; Eliseĭkina LV; Lanchuk SG
Revmatologiia (Mosk); 1988; (2):23-6. PubMed ID: 3051271
[No Abstract] [Full Text] [Related]
5. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
[No Abstract] [Full Text] [Related]
6. [Developing a clinical classification of systemic scleroderma].
Guseva NG
Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860
[No Abstract] [Full Text] [Related]
7. [Survival and prognostic significance of a kidney lesion in systemic scleroderma].
Guseva NG; Anikina NV; Balabanova RM
Ter Arkh; 1982; 54(7):99-102. PubMed ID: 7135234
[No Abstract] [Full Text] [Related]
8. [A case of a combination of systemic scleroderma with diffuse eosinophilic fasciitis].
Krasovskiĭ II; Shkodkin IV; Vladimirova NN
Ter Arkh; 1996; 68(9):84-5. PubMed ID: 9005625
[No Abstract] [Full Text] [Related]
9. Scleroderma: living with unpredictability.
Acorn S; Joachim G; Wachs JE
AAOHN J; 2003 Aug; 51(8):353-7; quiz 358-9. PubMed ID: 12934863
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of scleroderma cases.
Chakravarty J
Indian J Dermatol; 1966 Jul; 11(4):109-12. PubMed ID: 5969950
[No Abstract] [Full Text] [Related]
11. Systemic sclerosis: a critical digest of the recent literature.
Barsotti S; Stagnaro C; Della Rossa A
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S3-14. PubMed ID: 26243174
[TBL] [Abstract][Full Text] [Related]
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma).
Bull Rheum Dis; 1981; 31(1):1-6. PubMed ID: 7459513
[No Abstract] [Full Text] [Related]
13. Screening for pulmonary hypertension in scleroderma: how and when to look?
Mehta S; Little S
J Rheumatol; 2006 Feb; 33(2):204-6. PubMed ID: 16465647
[No Abstract] [Full Text] [Related]
14. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
15. The development of systemic sclerosis (scleroderma) following augmentation mammoplasty.
Appleton BE; Lee P
J Rheumatol; 1993 Jun; 20(6):1052-4. PubMed ID: 8350312
[TBL] [Abstract][Full Text] [Related]
16. What does the clinician need to improve patient care in systemic sclerosis?
Vonk MC; van den Hoogen FH; van Riel PL; Valentini G
Ann Rheum Dis; 2007 Sep; 66(9):1129-31. PubMed ID: 17693603
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of selected rheumatologic diseases.
Ostezan LB; Callen JP
Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
[TBL] [Abstract][Full Text] [Related]
18. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Curr Opin Rheumatol; 1997 Nov; 9(6):B199-206. PubMed ID: 9375289
[No Abstract] [Full Text] [Related]
19. [Malignant scleroderma].
Pavelka K; Stáva Z; Pazderka V; Dostál C
Fysiatr Revmatol Vestn; 1971 Apr; 49(2):81-8. PubMed ID: 5103333
[No Abstract] [Full Text] [Related]
20. [Classification of systemic progressive sclerosis].
Reumatizam; 1996; 43(1):25-7. PubMed ID: 8966376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
